dihexa hgf c met potentiator

dihexa hgf c met potentiator The HGF/c-Met Axis: A Promising Therapeutic Target in Cancer Frontiers | HGF and MET:

Name: dihexa hgf c met potentiator The HGF/c-Met Axis: A Promising Therapeutic Target in Cancer Frontiers | HGF and MET:
Brand: lagence-mr.com
SKU: 56550709612
Price: 20.10 USD
Availability: InStock
Rating: 4.2925 (7 reviews)

Frontiers HGF and MET: From Brain Development to Neurological Disorders HGF c MET: A Promising Therapeutic Target in the Digestive System Cancers Frontiers HGF c Met: A Key Promoter in Liver Regeneration Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted Activated HGF c Met Axis in Head and Neck Cancer

SKU: 56550709612 · From lagence-mr.com

4.3

USD20.10 USD53.10

Pay in 4 interest-free payments of $5.03 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 14 - Sep 19

Description

The vote is not binding

Irfan Khan, MD Dr

Gastrointestinal symptoms, primarily nausea, vomiting, and diarrhea, are most common during the dose escalation phase and typically improve after 4 to 8 weeks at a stable dose